Este papel biolgico es real, pero la pregunta prctica es: tomarla como suplemento cambia algo de forma relevante
Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, OFarrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Milicevic Z (2022) LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
GLP-1s are among the most expensive weight loss medications, with monthly costs often exceeding $1,000
Bimagrumab has the potential of improving the WL quality by preserving lean mass and could become an attractive treatment option for sarcopenic obesity
Muscle matters: the effects of medically induced weight loss on skeletal muscle
Its primary use is diluting or reconstituting medications for intravenous (IV), intramuscular (IM), or subcutaneous (SC) injection